Interferon beta-1b and childhood multiple sclerosis

Pediatric Neurology

Volumn 21, Issue 1, 1999, Pages 481-483

  Adams, Alexa B ^a   Tyor, William R ^b   Holden, Kenton R ^c  

^a Division of Biostatistics   (United States)

^b Depts Neurol Microbiol Immunol   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON BETA SERINE; NEUTRALIZING ANTIBODY; STEROID;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; HUMAN; LONG TERM CARE; MALE; MULTIPLE SCLEROSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RELAPSE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; CHILD; DRUG ADMINISTRATION SCHEDULE; GAIT; HUMANS; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; RECURRENCE; TREATMENT OUTCOME; VISION;

EID: 0032991525     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(99)00007-7     Document Type: Article

References (9)

1. Ghezzi A., Deplano V., Faroni J., et al. Multiple sclerosis in childhood Clinical features of 149 cases . Mult Scler. 3:1997;43-46.
2. Wakai S., Watanabe Y., Ichiki T., et al. Childhood multiple sclerosis MR images and clinical variations in four Japanese cases . Brain Dev. 16:1994;52-56.
3. Iannetti P., Marciani M.G., Spalice A., et al. Primary CNS demyelinating diseases in childhood Multiple sclerosis . Childs Nerv Syst. 12:1996;149-154.
4. Interferon beta-1b in the treatment of multiple sclerosis Final outcome of the randomized controlled trial . Neurology. 45:1995;1277-1285.
5. Cole G.F., Stuart C.A. A long perspective on childhood multiple sclerosis. Dev Med Child Neurol. 37:1995;661-667.
6. Weinstock-Guttmann B., Ransohoff R.M., Kinkel R.P., Rudick R.A. The interferons Biologic effects, mechanisms of action, and use in multiple sclerosis . Ann Neurol. 37:1995;7-15.
7. Kivisakk P., Alm G.V., Tian W.Z., Matusevicius D., Fredrikson S., Link H. Neutralising and binding anti-interferon-beta-1b antibodies during IFN-beta-1b treatment of multiple sclerosis. Mult Scler. 3:1997;184-190.
8. Neutralising antibodies during treatment of multiple sclerosis with interferon beta-1b Experience during the first three years . Neurology. 47:1996;889-894.
9. Arnason BG, Dianzani F, co-chairs. Executive summary. Monograph of the International Workshop on Interferon Antibodies. New York, 1997.